S&amp;P may cut Merck&#39;s &quot;AAA&quot; credit rating
22097
Standard &amp; Poor&#39;s on Monday said it may cut its ratings on Merck &amp; Co Inc.(MRK.N: Quote, Profile, Research) , citing increasing concern about possible litigation relating to Merck&#39;s arthritis drug Vioxx.
182282
In New York, the blue-chip Dow Jones average fell on Thursday after drug maker Merck &amp; Co withdrew its widely used Vioxx painkiller after evidence showed the drug could increase risk of heart attack and stroke.
769773
TRENTON, N.J. -- Shares of drug maker Merck &amp; Co. dropped 2.5 percent in heavy trading yesterday, a day after medical journal reports offered fresh ammunition to patients suing over its withdrawn painkiller Vioxx.
318703
Standard &amp; Poor's on Wednesday said it cut or may cut its ratings on $270 billion worth of U.S. mortgage-backed securities while putting $264 billion of collateralized debt obligations on watch for a possible downgrade.
203516
Standard & Poor's may cut $12 billion of subprime-related debt on expectations for an 8 percent drop in U.S. home prices and more defaults on home loans, the rating company said on Tuesday.
61157
Standard & Poor's said on Tuesday it may cut ratings on $12.1 billion of mortgage-related debt this week on expectations for an 8 percent drop in U.S. home prices and more mortgage defaults.
597746
Industry analysts are predicting US regulators this month will refuse to approve Merck &amp; Co.&#39;s new arthritis drug until at least 2006 because of heart attacks linked to its recalled sister drug Vioxx.
734034
Standard &amp; Poor&#39;s said on Tuesday it may cut the corporate credit rating of The Interpublic Group of Cos. (IPG.N: Quote, Profile, Research) citing growing concerns over senior
514713
BETHESDA, Md.  - U.S. advisers are set to decide  on Friday whether they will recommend approval for Merck & Co.  Inc.'s plan to sell a cholesterol-lowering medicine on  drugstore shelves without a prescription.
417092
The Philippines may have its long-term debt ratings cut by Moody&#39;s Investors Service, which cited the government&#39;s budget deficit and debt.
140168
Merck &amp; Co Inc. on Thursday pulled its arthritis drug Vioxx off the market because it increases the risk of heart attack and stroke, a move that sent the company&#39;s
233794
Merck & Co Inc. Thursday pulled its  arthritis drug Vioxx off the market because it increases the  risk of heart attack and stroke, a move that sent its shares  plunging, erasing $25 billion of its market value.
724445
Wall Street closed out a dismal third quarter with a mixed performance Thursday after Merck &amp; Co. said it would be forced to remove its best-selling Vioxx arthritis drug from the market.
258313
Merck (nyse: MRK - news - people ) will conduct its annual analyst meeting tomorrow. The drug company is expected to provide information regarding liabilities for potential Vioxx-related lawsuits.
768203
NEW YORK - Stocks were mixed Thursday after Merck & Co. said it would be forced to remove its best-selling Vioxx arthritis drug from the market due to serious health risks...
515664
Pharmaceutical giant Merck &amp; Co., under siege over revenues lost since it recalled arthritis drug Vioxx, will have cut about 5,100 jobs by year&#39;s end, 700 more than first planned, and will slash costs by $2.4 billion over four years, chairman and CEO
764330
U.S. stock futures pointed to a  slightly lower open on Tuesday as investors take a step back  after last week's three-day rally, with shares of drug maker  Merck & Co. MRK.N under pressure as regulators step up  investigations into the company's withdrawal of its pain  reliever, Vioxx.